Optibodies™ are a series of monoclonal antibodies for immunohistochemistry developed by Nordic Biosite. They were created to boost quality and create options for users of IHC biomarkers in clinical pathology.
High quality is our drive, our IHC experts have a high level of competence and we have our own R&D and production. Only antibodies that reach excellent results in testing protocol and appropriate control tissues are approved as part of the collection. An important aspect is being user-friendly, Optibodies work for different protocols and platforms with standard buffers. Optibodies™ get high scores in NordiQC assessments which is a confirmation of the high quality.
Would you be interested in testing out Optibodies in your own lab, please contact us at firstname.lastname@example.org and we would be happy to discuss the options with you. Protocols for IHC automation platforms are available at the Optibodies product page.
Our top-performing Optibodies™
We want you to experience the high quality of our Optibodies™ and we want to make it easy for you. Check out the images and the protocols for our Pan Cytokeratin, EpCAM and Napsin A, all CE/IVD marked. We have protocols for Ventana Benchmark Ultra and Dako Omnis if you want to test them in your own lab.
Cytokeratins are expressed in a wide variety of epithelial tissues and are of great importance for carcinoma diagnostic. The challenge is to stain all the 20 different cytokeratins optimally. BS5 clone meets this challenge as one of the best clones on the market. The main advantage of the clone is the monoclonality, providing robust performance independent of the tissue and between many protocols.
Ep-CAM, is an epithelial marker and can be of great help in the differential diagnosis of malignancies in the peritoneal and pleural cavities. The advantage of the BS14 clone is its robustness and optimal performance on multiple IHC platforms, using standard high pH HIER buffer. The BS14 clone is a good alternative with more flexible dilution range.
Napsin A is predominantly expressed in the lung and kidney. It is important in the differential diagnosis of lung adenocarcinoma vs. squamous cell carcinoma. The main advantage of BS10 is its excellent performance, being sensitive and specific as well as easy to optimize.